COLD SORE TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Growing demand for over-the-counter drugs

There has been growing preference among consumers to self-treat common health conditions without visiting a doctor. Cold sores, being a recurrent but generally mild illness, are often self-treated at home using over-the-counter products. The availability of a wide variety of effective OTC for cold sore treatments can drive the market growth. These include topical antiviral creams containing drugs like acyclovir and penciclovir, lip balm formulations, analgesic gels to relieve pain/tingling sensation, and medicated patches. Consumers find OTC drugs more convenient as these can be purchased easily without a prescription from retail pharmacies and drug stores. This helps save the time and expense of a doctor's visit for a condition that does not require professional medical intervention in most cases. With hectic lifestyles, there has been huge demand for quick and effective self-treatment options. Positive reviews and recommendations shared on digital platforms have boosted confidence in OTC brands. Furthermore, innovative product formats like roll-on applicators and thin films improve consistency of drug application and offer convenience. Growing consumer awareness about trigger management and available treatment options can contribute to increased reliance on OTC medications for self-care of cold sores.

• GSK plc
• Novartis AG
• Teva Pharmaceuticals USA, Inc.
• AbbVie Inc.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi
• Mylan N.V.
• Aurobindo Pharma
• Reddy's Laboratories
• Amgen Inc.
• GlaxoSmithKline
• Ferring Pharmaceuticals
• HRA Pharma
• Quantum Health
• Church & Dwight Co., Inc.
• Perrigo Company plc
• Biofrontera AG
• Bausch Health Companies Inc.
• Meda Pharmaceuticals